vivoPharm acquires RDDT

Posted on 11 APRIL 2012: RMIT University and vivoPharm today jointly announced the sale of RMIT Drug Discovery Technologies Pty Ltd (RDDT) to vivoPharm Pty Ltd. As a result of the share based transaction RMIT will become a 20% shareholder in vivoPharm.RDDT is a Good Laboratory Practice (GLP)-compliant pre-clinical toxicology testing company founded and owned by RMIT. RDDT’s operations will continue at the RMIT Bundoora campus, which will become vivoPharm’s Australian headquarters.

Read more

Previous ArticleNext Article